Clinical Trial Update: A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults [Phase 1, Phase 2]

View source ↗

Summary

A Pfizer study evaluating a modified RNA vaccine for herpes zoster (shingles) in healthy adults has terminated its Phase 1/2 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Pfizer shingles mRNA vaccine (modified RNA vaccine)

Snippet

Sponsor: Pfizer | Conditions: Shingles, Herpes Zoster Infection | Phase 1, Phase 2 | Status: TERMINATED